Page 32 - Journal of Special Operations Medicine - Fall 2015
P. 32

Junctional Tourniquet Training Experience



                         John F. Kragh Jr, MD; James J. Geracci, MD; Donald L. Parsons;
                  John B. Robinson; Kimberlie A. Biever; Erling B. Rein MD; Elon Glassberg MD;
                   Geir Strandenes MD; Jacob Chen MD; Avi Benov MD; David Marcozzi MD;
                       Stacy Shackelford MD; Kevin M. Cox; Elizabeth A. Mann-Salinas PhD






          ABSTRACT

          Since 2009, out-of-hospital care of junctional hemor-  local military units, if they choose, pay for their own
          rhage bleeding from the trunk–appendage junctions has   tourniquets and provide their own training.
          changed, in part, due to the newly available junctional
          tourniquets (JTs) that have been cleared by the US Food   Since the topic of JT use is so new, the depth of the ex-
          and Drug Administration. Given four new models of JT   perience of such training and trainers is currently shal-
          available in 2014, several military services have begun   low, but the collective experience is broad. This may be
          to acquire, train, or even use such JTs in care. The abil-  valuable for audiences consisting of those people who
          ity of users to be trained in JT use has been observed   wish to train with JTs in the future, for those who wish
          by multiple instructors. The experience of such instruc-  to train others, or for those who need to make decisions
          tors has been broad as a group, but their experience as   about training. However, currently, there is no docu-
          individuals has been neither long nor deep. A gathering   mented record of such experiences.
          into one source of the collective experience of trainers
          of JT users could permit a collation of useful informa-  Experiences such as lessons learned, principles of use,
          tion to include lessons learned, tips in skill performance,   tips to emphasize, and pitfalls to avoid would be useful
          identification of pitfalls of use to avoid, and strategies   as a guide to future lesson plans, to training programs,
          to optimize user learning. The purpose of the present   and, ultimately, to best care. The purpose of this review
          review is to record the experiences of several medical   is to record the experiences of medical personnel in train-
          personnel in their JT training of users to provide a guide   ing of JT users, to provide a guide for future trainers.
          for future trainers.
                                                             Models of JTs in 2014
          Keywords: hemorrhage, resuscitation, medical device, edu-
          cation, skill development, emergency medical services  Currently, four models of JTs that have been cleared by
                                                             the US Food and Drug Administration (FDA) are avail-
                                                             able for use. Since FDA clearance, labeling of three mod-
                                                             els has changed (Table 1), and one company changed its
          Introduction
                                                             model’s name.
          Junctional hemorrhage—bleeding from wounds at the
          junction of the torso and its appendages—is common   Combat Ready Clamp
          in the current wars in Afghanistan and Iraq, and, if un-  The  Combat  Ready  Clamp  (CRoC )  (Combat  Medi-
                                                                                            ™
          controlled, it can be lethal.  Although labeled in 2009   cal Systems; combatmedicalsystems.com) is a vascular
                                 1–3
          by Tai and Dickson,  junctional bleeding is ancient; the   clamp that was the first FDA-cleared JT (Figure 1).  The
                            4
                                                                                                         8
          recent focus is on controlling it better. 4–7      CRoC was first cleared for groin use and subsequently
                                                             cleared for axilla use.  A letter to the FDA was accepted
                                                                               10
          To control junctional bleeding, multiple junctional tour-  that allowed periumbilical use of the CRoC for difficult
          niquets (JTs) are now available in the marketplace, and   inguinal bleeding. By labeling, use of the CRoC is cur-
          each model has at least some evidence of both safety and   rently confined to the battlefield. Evidence supportive
          effectiveness. 8–11  Users of JTs have been trained in their   of CRoC use includes a case report, a normal volunteer
          application, and the novelty of the training with these   study, a manikin study, and animal and cadaver stud-
          recently fielded devices has led to varied experiences for   ies. 10,12–18  Furthermore, the instructions for use and the
          both users and trainers. Furthermore, issue to those in   way the CRoC was packaged were changed to full as-
          the field has been limited and informal, as no doctrinal   sembly in a ready-to-use configuration and not in the
          enactment decision has been executed service-wide, so   prior unassembled state.



                                                          20
   27   28   29   30   31   32   33   34   35   36   37